Testing effectiveness (Phase 2)Study completedNCT00026533What this trial is testingThalidomide in Treating Patients With Thyroid CancerWho this might be right forHead and Neck Cancer Kenneth Ain
Early research (Phase 1)Study completedNCT01576692What this trial is testingCombination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory NeuroblastomaWho this might be right forNeuroblastoma St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00003408What this trial is testingBiological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Cancer Treatment Centers of America 40
Early research (Phase 1)Study completedNCT02761915What this trial is testingA Phase I Trial of Anti-GD2 T-cells (1RG-CART)Who this might be right forRelapsed or Refractory Neuroblastoma Cancer Research UK 17
Testing effectiveness (Phase 2)Looking for participantsNCT06425926What this trial is testingSafety and Tolerability Study of GIM-531 in Advanced Solid TumorsWho this might be right forMelanoma Stage IVSolid Tumor Georgiamune Inc 117
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01866449What this trial is testingProspective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme (GBM) WHO Grade IV University of Ulm 24
Testing effectiveness (Phase 2)UnknownNCT00013806What this trial is testingCHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II StudyWho this might be right forNeuroblastoma National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213704What this trial is testingLarotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor+30 more National Cancer Institute (NCI) 9
Early research (Phase 1)Ended earlyNCT04239092What this trial is testing9-ING-41 in Pediatric Patients With Refractory Malignancies.Who this might be right forRefractory CancerRefractory NeoplasmCancer Pediatric+8 more Actuate Therapeutics Inc. 40
Large-scale testing (Phase 3)Study completedNCT01305200What this trial is testingSupersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell TransplantWho this might be right forChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more Children's Oncology Group 226
Early research (Phase 1)Ended earlyNCT01552434What this trial is testingBevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseWho this might be right forAdvanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more M.D. Anderson Cancer Center 154
Early research (Phase 1)Active Not RecruitingNCT04007744What this trial is testingSonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more Mayo Clinic 36
Early research (Phase 1)Study completedNCT00075634What this trial is testingDecitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or NeuroblastomaWho this might be right forRecurrent NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00254579What this trial is testingStudy of CP-675,206 in Refractory MelanomaWho this might be right forRefractory Melanoma AstraZeneca 251
Early research (Phase 1)Ended earlyNCT02164097What this trial is testingODSH + ICE Chemotherapy in Pediatric Solid TumorsWho this might be right forRecurrent Solid TumorRefractory Solid TumorSarcoma+2 more New York Medical College 4
Early research (Phase 1)UnknownNCT03385486What this trial is testingStudy of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint InhibitorsWho this might be right forStage III MelanomaStage IV Melanoma Taiga Biotechnologies, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT01962103What this trial is testingStudy to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsWho this might be right forNeuroblastomaRhabdomyosarcomaEwing's Sarcoma+20 more Celgene 107
Testing effectiveness (Phase 2)Study completedNCT00003173What this trial is testingHigh-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more Memorial Sloan Kettering Cancer Center 36
Early research (Phase 1)Looking for participantsNCT04254419What this trial is testingPhase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer CellsWho this might be right forHigh Grade Glioma Nationwide Children's Hospital 18